Transplant Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Transplant Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global transplant diagnostics market size reached US$ 804.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,319.8 Million by 2028, exhibiting a growth rate (CAGR) of 8.60% during 2022-2028.

Transplant diagnostics are the basis for histocompatibility and immunogenetics of organ and hematopoietic stem cell transplantations. They assist healthcare professionals in determining the compatibility between potential organ donors and recipients. They increase the chances of organ survival while minimizing serious transplant complications. As a result, they are used in various disciplines, such as pathology, immunogenetics, infectious diseases, molecular diagnostics, therapeutic drug monitoring, and human leukocyte antigens (HLA) typing and monitoring.

Transplant Diagnostics Market Trends:
The growing prevalence of acute and chronic diseases on account of the increasing consumption of processed food products and the escalating number of individuals that smoke tobacco products and consume alcohol is causing a significant rise in the number of organ failure cases. This, in confluence with the growing number of blood donors, represents one of the primary factors driving the demand for transplant diagnostics worldwide to ensure donor-recipient compatibility and improve the quality of life of transplant patients. Moreover, as older people are more prone to health problems and organ failure, the rising geriatric population across the globe is contributing to market growth. The escalating number of severe road accidents or collisions is also influencing the demand for organ transplantation and its diagnostics. Apart from this, manufacturers are offering a comprehensive range of antibody detection products, laboratory instrumentation, and computer software. These products can be utilized to simplify and automate testing procedures and final test evaluations, which is creating a favorable market outlook. Furthermore, the increasing expenditure in the healthcare sector by governments of several countries is impelling the market growth. Furthermore, several healthcare firms are focusing on developing innovative, high-quality HLA products for clinical and research applications, which, in turn, is projected to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transplant diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, technology, organ type, application and end user.

Breakup by Component:

Instrument and Equipment
Reagent and Consumables
Software and Services

Breakup by Technology:

Non-Molecular Assay
Serological Assay
Mixed Lymphocyte Culture
Molecular Assay
PC-based
Sequencing-based

Breakup by Organ Type:

Kidney
Liver
Heart
Lung
Pancreas
Others

Breakup by Application:

Pre-Transplant Diagnostics
Post-Transplant Diagnostics

Breakup by End User:

Hospitals and Transplant Centers
Research Laboratories and Academic Institutes
Commercial Service Providers

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc, Illumina Inc., Immucor Inc. (IVD Holdings Inc.), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:
How has the global transplant diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global transplant diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the component?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the organ type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global transplant diagnostics market and who are the key players?
What is the degree of competition in the industry?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Transplant Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Instrument and Equipment
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagent and Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Non-Molecular Assay
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Serological Assay
7.1.2.2 Mixed Lymphocyte Culture
7.1.3 Market Forecast
7.2 Molecular Assay
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 PC-based
7.2.2.2 Sequencing-based
7.2.3 Market Forecast
8 Market Breakup by Organ Type
8.1 Kidney
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Liver
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Heart
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Lung
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Pancreas
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Pre-Transplant Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Post-Transplant Diagnostics
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals and Transplant Centers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Research Laboratories and Academic Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Commercial Service Providers
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 bioMérieux SA
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bio-Rad Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 F. Hoffmann-La Roche AG
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 SWOT Analysis
16.3.6 Hologic Inc
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Illumina Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Immucor Inc. (IVD Holdings Inc.)
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 SWOT Analysis
16.3.9 Merck KGaA
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Qiagen N.V.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings